Planegg/Martinsried (24.06.2024) - Shareholders approve all proposed resolutions - Re-election of two members of the Supervisory Board- Reduction of share capital by consolidation of shares at a ratio of 2:1 approved - Creation of new authorized capital provide the Company with operational and strategic flexibility Medigene AG (Medigene, the "Company", FSE: MDG1, Prime Standard), an immuno-oncology platform ...
[ more ]
